You searched for "vision"

2432 results found

Registration live for 100% Ophthalmology 2025

Organisers of 100% Optical have announced that visitor registrations for 100% Ophthalmology 2025 are now live for the show set to take place at London’s ExCeL from 1–3 March. Featuring as a co-located event with 100% Optical, 100% Ophthalmology, a...

From stereoblind to stereopsis

This study sought to examine the postoperative stereopsis in stereoblind patients with normal or corrected visual acuity. Twenty patients (10 female / male) with an average age of 25.35±6.34 years were studied with primary horizontal comitant strabismus (14 exotropia, six...

BT as an effective alternative treatment for small angle consecutive exotropia

In this study, the authors evaluate the efficacy of botulinum toxin A (BTA) as a treatment option for consecutive exotropia. This was a retrospective review of 34 patients; 23 female and 11 male. Age at BTA was a mean of...

BCLA to stage its first in-person Presidential Address since pandemic

The new President of the BCLA will highlight the “fears and opportunities” in the contact lens industry as part of the first face-to-face address to members in four years.

Moorfields International Corneal & Cataract Symposium 2024

Mr Alexander Ionides & Mr Mark Wilkins, supported by Théa Pharmaceuticals, NuVison Biotherapies, Altomed Ltd. and Daybreak Medical, are pleased to invite you to register your place for the 2024 Moorfields International Corneal & Cataract Symposium! The programme is under construction and will include 14 talks on current Cornea & Cataract topics from Moorfields, UK and international keynote speakers. Confirmed keynote speakers include Dr Soosan Jacob from Dr Agarwal’s Group of Eye Hospitals, Chennai, India, Prof Adnan Tufail and Prof Paul Foster from Moorfields Eye Hospital NHS Foundation Trust. Thea are pleased to be the gold sponsors of this event along with Altomed, NuVision and Daybreak - silver sponsors.

Newer generation IOL platforms designed for high-quality visual performance after cataract surgery

Expanding intraocular lens (IOL) capabilities provide broadening options, ranging from next-generation monofocal IOLs for basic cataract surgery, to specialised premium IOLs for lens-based presbyopia correction and astigmatism correction at the time of cataract surgery. Rod McNeil considers several newer alternative...

AAPOS (American Association for Pediatric Ophthalmology and Strabismus) 50th Annual Meeting

50th AAPOS Annual MeetingMarch 5 - 9, 2025 Celebrate the milestone anniversary of the AAPOS Annual Meeting at the elegant Grand America Hotel in the heart of Salt Lake City, Utah! Join us as we gather to honor the past,...

IWD 2024: Women-led eye care is helping to shrink the blindness gender gap in Bangladesh

International Women's Day 2024 - a lack of female health providers is stealing the sight of women around the world. Blindness prevention charity Orbis is working to change this.

My Top Five: Red flag presentations all resident doctors must know

Ophthalmic emergencies are time-critical situations where delays in recognition or management can lead to permanent vision loss [1]. For resident doctors and medical students, identifying these red flags can be daunting, especially given the complexity of the eye and its...

Through the eyes of artists, part two: The effects of retinal degeneration on Degas and O’Keeffe

Last issue we discussed Monet and Cassatt’s experience of painting through cataract. We now move to two stories of resilience in the face of macular degeneration, Edgar Degas and Georgia O’Keeffe. Edgar Degas. (c1873) ‘The Dance Class’, oil on canvas....

Leading eye care charity Orbis teams up with Espresso Solutions to celebrate Father’s Day

This Father’s Day, Orbis are offering everyone the chance to win a top-of-the-line coffee machine.

Corporate M&A pace gathers momentum

Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...